MRK R&D to Revenue
Merck & Co. · R&D to Revenue
MRK R&D to Revenue
Latest reported58.66%period ending
MRK Quarterly R&D/Revenue (0.00% → 58.66%)
Latest values, visible window
High-resolution chart · PNG
MRK r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 58.656% | |
| 77.1092% | |
| 15.3087% | |
| 20.6716% | |
| 22.4051% | |
| 19.9693% | |
| 29.3395% | |
| 35.1924% | |
| 21.7229% | |
| 25.3059% | |
| 65.8031% | |
| 20.718% | |
| 88.5999% | |
| 29.5161% | |
| 27.2957% | |
| 29.407% | |
| 19.1736% | |
| 16.2002% | |
| 22.6906% | |
| 18.5875% | |
| 37.8969% | |
| 22.6969% | |
| 46.64% | |
| 30.6432% | |
| 22.2923% | |
| 18.3213% | |
| 21.4695% | |
| 25.845% | |
| 18.6139% | |
| 17.8532% | |
| 20.1309% | |
| 19.1588% | |
| 21.7296% | |
| 31.8422% | |
| 21.8633% | |
| 42.7409% | |
| 17.9456% | |
| 19.3979% | |
| 45.9614% | |
| 15.7935% | |
| 21.8509% | |
| 17.8157% | |
| 17.6016% | |
| 14.8913% | |
| 17.0669% | |
| 18.4297% | |
| 21.7802% | |
| 15.7147% | |
| 15.2186% | |
| 15.3352% | |
| 16.2102% | |
| 15.0471% | |
| 19.0827% | |
| 17.8709% | |
| 18.9486% | |
| 16.6957% | |
| 17.5859% | |
| 15.8725% | |
| 19.6763% | |
| 16.2535% | |
| 15.9328% | |
| 18.6356% | |
| 37.35% | |
| 20.8719% | |
| 19.205% | |
| 17.9566% | |
| 19.5324% | |
| 20.7283% | |
| 23.6496% | |
| 22.7327% | |
| 22.9859% | |
| 19.7026% | |
| 19.3215% | |
| 18.5208% | |
| 22.1339% | |
| 23.7154% | |
| 16.8619% | |
| 17.8528% | |
| 28.5071% | |
| 17.4738% | |
| 20.3146% | |
| 17.4128% | |
| 19.2858% | |
| 17.4033% | |
| 17.3169% | |
| 15.7883% | |
| 19.287% | |
| 16.5996% | |
| 16.3741% | |
| 17.6938% | |
| 15.9034% | |
| 13.4762% | |
| 14.2325% | |
| 14.5511% | |
| 6.0266% | |
| 12.4749% | |
| 4.9275% | |
| 4.3577% | |
| 5.7048% | |
| 4.9523% |